(UroToday.com) Prostate cancer after primary non-surgical treatment of prostate cancer is common. The vast majority of recurring patients (~90%) undergo androgen deprivation therapy, regardless of the recurrence site. However, certain men with biochemical recurrence after primary treatment can be managed with curative intent by salvage radical prostatectomy. Historical series show high complication rates and poor outcomes, while better results are reported in novel robotic salvage radical prostatectomy procedures. At the American Urological Association (AUA) 2020 virtual annual meeting, Dr. Giancarlo Marra and colleagues presented results of their study assessing the contemporary oncological outcomes of salvage radical prostatectomy in a large multicenter recent series.